Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 11:22 PM
Study NCT ID:
NCT00540293
Status:
COMPLETED
Last Update Posted:
2021-03-12
First Post:
2007-10-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-04
First Submit QC Date:
None
Study First Post Date:
2007-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-05-08
Results First Submit QC Date:
None
Results First Post Date:
2009-06-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-17
Last Update Post Date:
2021-03-12
Last Update Post Date Type:
ACTUAL